Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
- PMID: 16973750
- PMCID: PMC1599986
- DOI: 10.1073/pnas.0606836103
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
Erratum in
- Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17554
Abstract
Androgen independence is responsible for most prostate cancer lethality, yet currently there are no effective clinical treatments. We have been investigating the mechanisms underlying androgen-independent prostate cancer in Nkx3.1;Pten mutant mice, which display salient features of the disease, including a requirement for wild-type androgen receptor (AR) signaling. We now demonstrate that the Akt and Erk MAP kinase signaling pathways are activated in androgen-independent lesions of these mice. Forced activation of either Akt or Erk signaling in an androgen-responsive prostate cancer cell line promotes hormone-independent but AR-dependent growth in culture. Although these pathways act additively in culture, they act synergistically in vivo to promote tumorigenicity and androgen independence in the context of the prostate microenvironment. We propose that androgen independence emerges by means of epithelial-stromal competition, in which activation of Akt and Erk promotes AR activity in the prostate epithelium while counteracting antagonistic effects of the stroma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Pten inactivation and the emergence of androgen-independent prostate cancer.Cancer Res. 2007 Jul 15;67(14):6535-8. doi: 10.1158/0008-5472.CAN-07-1271. Cancer Res. 2007. PMID: 17638861 Review.
-
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18. Adv Enzyme Regul. 2006. PMID: 16854453
-
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.Endocr Relat Cancer. 2005 Mar;12(1):119-34. doi: 10.1677/erc.1.00835. Endocr Relat Cancer. 2005. PMID: 15788644
-
An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.Biol Chem. 2008 Jun;389(6):773-80. doi: 10.1515/BC.2008.072. Biol Chem. 2008. PMID: 18627304
-
Akt in prostate cancer: possible role in androgen-independence.Curr Drug Metab. 2003 Dec;4(6):487-96. doi: 10.2174/1389200033489226. Curr Drug Metab. 2003. PMID: 14683476 Review.
Cited by
-
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer.PLoS One. 2016 Apr 5;11(4):e0152861. doi: 10.1371/journal.pone.0152861. eCollection 2016. PLoS One. 2016. PMID: 27046225 Free PMC article.
-
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.Cancers (Basel). 2022 Sep 23;14(19):4626. doi: 10.3390/cancers14194626. Cancers (Basel). 2022. PMID: 36230550 Free PMC article.
-
Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets.Am J Cancer Res. 2021 Apr 15;11(4):1012-1030. eCollection 2021. Am J Cancer Res. 2021. PMID: 33948343 Free PMC article. Review.
-
Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.Mol Cancer. 2014 Mar 19;13:61. doi: 10.1186/1476-4598-13-61. Mol Cancer. 2014. PMID: 24642271 Free PMC article.
-
Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse (Mus musculus) anterior prostate.Oncol Lett. 2015 Oct;10(4):2142-2148. doi: 10.3892/ol.2015.3522. Epub 2015 Jul 22. Oncol Lett. 2015. PMID: 26622809 Free PMC article.
References
-
- Hellerstedt BA, Pienta KJ. CA Cancer J Clin. 2002;52:154–179. - PubMed
-
- Feldman BJ, Feldman D. Nat Rev Cancer. 2001;1:34–45. - PubMed
-
- Heinlein CA, Chang C. Endocr Rev. 2004;25:276–308. - PubMed
-
- Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL. Nat Med. 2004;10:33–39. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous